Nusinersen Promising for Later-Onset Spinal Muscular Atrophy

WEDNESDAY, April 24, 2019 -- Limited evidence suggests that nusinersen treatment provides long-term benefits for children with later-onset spinal muscular atrophy (SMA), according to a study published online April 24 in Neurology. Basil T. Darras,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news